Etiologic theories of acrodermatitis enteropathica (AE) and the reasons for the efficacy of diiodohydroxyquin (Diodoquin) therapy were evaluated in a 21-year-old woman with this disorder. Controlled studies on a metabolic ward were carried out intermittently over a 2½ year period both with and without diiodohydroxyquin treatment. The proposed defect in tryptophan metabolism reported in the literature could not be verified. The adaptive response of jejunal glycolytic enzyme activity was normal. Electron microscopy demonstrated abnormal jejunal cytoplasmic inclusions in the fasting state. Serum lipids were consistently low, and lipoprotein electrophoresis showed hypobetalipoproteinemia. Arachidonic acid levels were repeatedly low. Of the previously proposed etiologic theories, we were able to implicate only a defect in lipid metabolism, the exact nature of which remains obscure. How diiodohydroxyquin might influence such a presumed defect is enigmatic.
Neldner KH, Hagler L, Wise WR, Stifel FB, Lufkin EG, Herman RH. Acrodermatitis Enteropathica: A Clinical and Biochemical Survey. Arch Dermatol. 1974;110(5):711–721. doi:10.1001/archderm.1974.01630110009001
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: